COVID-19 Vaccination Requirements and Laws
The US Centers for Disease Control and Prevention has clinical care guidelines for the three vaccines that have been approved – the two mRNA vaccines and the Jansen vaccine.
Relaxing Vaccine Dosage and Food Label Requirements
The Food and Drug Administration issues a press release that said, even though the pandemic is severe, patients should receive the mRNA vaccines in two properly timed doses.
How Have States Relaxed the Telemedicine Requirement of a Good Faith or Appropriate Prior Exam?
Many states are easing the restrictions on using telehealth during COVID including easing licensing requirements and in-person visit requirements.
Johnson and Johnson’s COVID-19 Vaccine Should Be Reviewed by FDA Soon
Johnson & Johnson’s adenovirus-based vaccine for preventing the transmission of COVID-19 is expected to be reviewed by the Food and Drug Administration in February 2021.
FDA Approves Authorized Use of a COVID-19 Test Product
FDA granted emergency use authorization to Lucira Health Inc. for a COVID-19 self-testing kit. The EUA has numerous conditions that the manufacturer must meet.
FDA Issues Emergency Use Authorization for Pfizer COVID-19 Vaccine
FDA granted an Emergency Use Authorization to a COVID-19 vaccine developed by Pfizer, Inc. Doses of the vaccine have already been administered to health workers
FDA Warning Letters To Companies Claiming Products Boost Immunity and Treat COVID-19
Federal Drug Administration continues to send warning letters to companies that boast products can treat, diagnose, prevent, or cure COVID-19 or boost immunity.
FDA Warning Letters Sent to Companies That Claim Products are Effective against COVID-19
Federal Drug Administration has started sending warning letters to companies that boast their products can treat, diagnose, prevent, or cure COVID-19 or boost immunity.
FTC Announces New Warning Letters to Companies Making False Coronavirus Claims
The Federal Trade Commission (FTC) announced the agency is sending warning letters to companies that claim its products can treat or prevent coronavirus (COVID-19) due to lack of scientific evidence
Frequently Asked Questions about Telehealth and HIPAA during the COVID-19 emergency
The Department of Health and Human Services has created a list of frequently asked questions and answers about using telehealth during the COVID-19 emergency
New Agency Telehealth Guidelines During COVID-19 Health Pandemic
In response to the public health emergency created by the novel coronavirus, various agencies such as the DHHS and FTC are announcing new compliance rules.
HIPAA COVID-19 Decision Tool
The OCR of the DHHS announced a new online decision tool to help HIPAA covered entities understand protected health information compliance during the COVID-19 emergency
COVID-19 HIPAA Compliance Requirements
The Department of Human Service’s Office of Civil Rights offers new HIPAA guidance during the COVID-19 public health emergency
Answers to Your Most Burning Employment Law Questions about COVID-19
The Coronavirus pandemic (COVID-19) has sent the United States into a tailspin. While the primary focus has been on containing the virus, employers have a lot of questions about how to handle [...]
